RESEARCH PAPER

Economic burden of smoking in China, 2000

H-Y Sung¹, L Wang², S Jin², T-W Hu³, Y Jiang²

¹ Institute for Health & Aging, School of Nursing, University of California, San Francisco, California, USA
² National Center for Public Health Surveillance and Information Services, Chinese Center for Disease Control and Prevention, Beijing, China
³ School of Public Health, University of California, Berkeley, California, USA

Correspondence to:
Correspondence to:
Hai-Yen Sung
PhD, Institute for Health & Aging, UCSF, 3333 California Street, Suite 340, San Francisco, CA 94118, USA; Hai-Yen.Sung{at}ucsf.edu

Objective: To assess the health-related economic burden attributable to smoking in China for persons aged 35 and older.

Methods: A prevalence-based, disease-specific approach was used to estimate the smoking attributable direct costs, indirect morbidity costs, and costs of premature deaths caused by smoking-related diseases. The primary data source was the 1998 China National Health Services Survey, which contains the smoking status, medical utilisation, and expenditures for 216 101 individuals.

Results: The economic costs of smoking in 2000 amounted to $5.0 billion (measured in 2000, US$) in total and $25.43 per smoker ( age 35). The share of the economic costs was greater for men than women, and greater in rural areas than in urban areas. Of the $5.0 billion total costs, direct costs were $1.7 billion (34% of the total), indirect morbidity costs were $0.4 billion (8%), and indirect mortality costs were $2.9 billion (58%). The direct costs of smoking accounted for 3.1% of China’s national health expenditures in 2000.

Conclusion: The adverse health effects of smoking constitute a huge economic burden to the Chinese society. To reduce this burden in the future, effective tobacco control programmes and sustained efforts are needed to curb the tobacco epidemic and economic losses.

Abbreviations: GDP, gross domestic product; ICD-9, International classification of diseases, 9th revision; NHSS, National Health Services Survey; PVLE, present value of lifetime earnings; RR, relative risk; SAF, smoking attributable fraction; SAI, smoking attributable indirect morbidity cost; THE, total health care expenditure; TIE, total indirect morbidity expenditure; YPLL, years of potential life lost

Keywords: China; cost; smoking

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Nakamura, K, Huxley, R, Ansary-Moghaddam, A, Woodward, M (2009). The hazards and benefits associated with smoking and smoking cessation in Asia: a meta-analysis of prospective studies. Tobacco Control 18: 345-353 [Abstract] [Full Text]  
• Li, L, Yong, H-H, Borland, R, Fong, G T, Thompson, M E, Jiang, Y, Yang, Y, Sirirassamee, B, Hastings, G, Harris, F (2009). Reported awareness of tobacco advertising and promotion in China compared to Thailand, Australia and the USA. Tobacco Control 18: 222-227 [Abstract] [Full Text]  
• John, R M, Sung, H-Y, Max, W (2009). Economic cost of tobacco use in India, 2004. Tobacco Control 18: 138-143 [Abstract] [Full Text]  
• Gu, D., Kelly, T. N., Wu, X., Chen, J., Samet, J. M., Huang, J.-f., Zhu, M., Chen, J.-c., Chen, C.-S., Duan, X., Klag, M. J., He, J. (2009). Mortality Attributable to Smoking in China. NEJM 360: 150-159 [Abstract] [Full Text]  
• Ross, H., Trung, D. V., Phu, V. X. (2007). The costs of smoking in Vietnam: the case of inpatient care. Tobacco Control 16: 405-409 [Abstract] [Full Text]  
• Sin, D. D., Tan, W. C. (2007). Breaking Down the "Great Wall" of COPD Care in China. Am. J. Respir. Crit. Care Med. 176: 732-733 [Full Text]